Marc JeanGilles, DO, FACOG provides guidance on what patients typically experience during the first week after starting Ozempic (semaglutide)
These include metformin, GLP-1 receptor agonists, GIP/GLP-1 therapy, SGLT2 inhibitors, DPP-4 inhibitors, insulin, and combination products
Nausea affects roughly 15 to 33% of users depending on the dose, with vomiting, diarrhea, and constipation following close behind
Geyer MC, Sullivan T, Tai A et al (2019) Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial
Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals